Abstract

Whole genome sequencing of cancer genomes has revealed a diversity of recurrent gross chromosomal rearrangements (GCRs) that are likely signatures of specific defects in DNA damage response pathways. However, inferring the underlying defects has been difficult due to insufficient information relating defects in DNA metabolism to GCR signatures. By analyzing over 95 mutant strains of Saccharomyces cerevisiae, we found that the frequency of GCRs that deleted an internal CAN1/URA3 cassette on chrV L while retaining a chrV L telomeric hph marker was significantly higher in tel1Δ, sae2Δ, rad53Δ sml1Δ, and mrc1Δ tof1Δ mutants. The hph-retaining GCRs isolated from tel1Δ mutants contained either an interstitial deletion dependent on non-homologous end-joining or an inverted duplication that appeared to be initiated from a double strand break (DSB) on chrV L followed by hairpin formation, copying of chrV L from the DSB toward the centromere, and homologous recombination to capture the hph-containing end of chrV L. In contrast, hph-containing GCRs from other mutants were primarily interstitial deletions (mrc1Δ tof1Δ) or inverted duplications (sae2Δ and rad53Δ sml1Δ). Mutants with impaired de novo telomere addition had increased frequencies of hph-containing GCRs, whereas mutants with increased de novo telomere addition had decreased frequencies of hph-containing GCRs. Both types of hph-retaining GCRs occurred in wild-type strains, suggesting that the increased frequencies of hph retention were due to the relative efficiencies of competing DNA repair pathways. Interestingly, the inverted duplications observed here resemble common GCRs in metastatic pancreatic cancer.

Highlights

  • Large numbers of complex chromosomal rearrangements are seen in many cancers, potentially due to ongoing genome instability

  • Genetic defects that suppressed de novo telomere addition increased hph retention, whereas genetic defects that increased de novo telomere addition decreased hph retention. These results suggest a mechanism by which Tel1, Sae2, and de novo telomere addition play a role in suppressing inverted duplications and, in some cases, interstitial deletions, and further demonstrate that defects in these pathways/ genes result in gross chromosomal rearrangements (GCRs) with a specific structural signature

  • The yel072w:: CAN1/URA3 GCR assay primarily mediates GCRs by duplication-mediated rearrangements with chromosomes IV, X, and XIV; the GCRs derived using this assay frequently lost the telomeric portion of chrV that includes the hph marker [14,21]

Read more

Summary

Introduction

Large numbers of complex chromosomal rearrangements (called gross chromosomal rearrangements or GCRs) are seen in many cancers, potentially due to ongoing genome instability. Some types of GCRs may be enhanced in subsets of cancer, including retrotransposition events in colorectal cancers [6], inversions in pancreatic cancer [7], tandem duplications in ovarian and triple-negative breast cancer [8,9], and focal copy number changes in ovarian cancer [10]. The presence of these rearrangements in a subset of cancers of a specific type suggests that the genetic background in different cancers may influence the mechanisms of GCRs formation. The limited understanding of the types of genetic defects that affect GCR formation and the enormous genetic variation seen in many cancers pose challenges to understanding the influence of genetic background on the types of GCRs seen and their rates of formation

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call